Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

2.6K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.6K
Disorders of Hemostasis01:24

Disorders of Hemostasis

2.7K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.7K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.4K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.4K
Disorders of Leukocytes01:27

Disorders of Leukocytes

2.3K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.3K
Replicative Cell Senescence02:15

Replicative Cell Senescence

3.5K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.5K
Telomeres and Telomerase02:41

Telomeres and Telomerase

23.0K
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
23.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel germline GATA1s-generating variant associates with somatic STAG2 variants in hypoplastic myelodysplastic neoplasm.

British journal of haematology·2026
Same author

Correction to: Off-label intravitreal eculizumab for geographic atrophy: report of the first two cases.

International journal of retina and vitreous·2026
Same author

Diagnosis and management of telomere biology disorders in developing countries.

Seminars in hematology·2026
Same author

Clonal Hematopoiesis Diversity in Aplastic Anemia - When Does It Matter Clinically?

NEJM evidence·2026
Same author

Off-label intravitreal eculizumab for geographic atrophy: report of the first two cases.

International journal of retina and vitreous·2026
Same author

American Society of Hematology 2026 Guidelines for the Diagnosis and Management of Severe Acquired Aplastic Anemia.

Blood advances·2026
Same journal

Artificial intelligence-driven multi-omics analysis of gut-kidney axis in chronic kidney disease.

Progress in molecular biology and translational science·2026
Same journal

Artificial intelligence in multi-omics analysis of heart diseases.

Progress in molecular biology and translational science·2026
Same journal

AI in multi-omics analysis of type 2 diabetes.

Progress in molecular biology and translational science·2026
Same journal

AI in multi-omics analysis in AMR.

Progress in molecular biology and translational science·2026
Same journal

AI in multi-omics analysis of COVID-19 patient data.

Progress in molecular biology and translational science·2026
Same journal

AI in multi-omics analysis of liver diseases.

Progress in molecular biology and translational science·2026
See all related articles

Related Experiment Video

Updated: Apr 27, 2026

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
11:06

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells

Published on: February 24, 2014

12.2K

Telomere dysfunction and hematologic disorders.

Raquel M A Paiva1, Rodrigo T Calado1

  • 1Department of Internal Medicine, University of São Paulo at Ribeirão Preto School of Medicine, Ribeirão Preto, São Paulo, Brazil.

Progress in Molecular Biology and Translational Science
|July 5, 2014
PubMed
Summary
This summary is machine-generated.

Telomere shortening and mutations in telomere biology genes cause aplastic anemia (AA) and bone marrow failure by impairing hematopoietic stem cell replication. These genetic factors also increase the risk of hematologic cancers.

Keywords:
Aplastic anemiaBone marrow failureDyskeratosis congenitaLeukemiaMyelodysplastic syndrome

More Related Videos

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

13.3K
Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

12.9K

Related Experiment Videos

Last Updated: Apr 27, 2026

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
11:06

Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells

Published on: February 24, 2014

12.2K
Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

13.3K
Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

12.9K

Area of Science:

  • Hematology
  • Genetics
  • Cell Biology

Background:

  • Aplastic anemia (AA) is characterized by the failure of hematopoietic stem cells to produce sufficient blood cells, leading to pancytopenia.
  • Acquired and inherited forms of AA, such as dyskeratosis congenita, are linked to telomere biology gene mutations and telomere shortening.
  • Telomere erosion critically impairs hematopoietic stem and progenitor cell replication, resulting in bone marrow failure.

Purpose of the Study:

  • To elucidate the role of telomere biology in the pathogenesis of aplastic anemia.
  • To investigate the connection between telomere shortening, gene mutations, and bone marrow failure.
  • To explore the association between telomere dysfunction and the risk of hematologic malignancies.

Main Methods:

  • Analysis of telomere length in hematopoietic stem cells.
  • Genetic sequencing to identify mutations in telomere biology genes.
  • Functional assays to assess stem and progenitor cell replication capacity.

Main Results:

  • Mutations in telomere biology genes and critically short telomeres were identified as etiologic factors in aplastic anemia.
  • Telomere erosion was shown to inhibit the replicative capacity of hematopoietic stem and progenitor cells.
  • Short telomeres and telomerase mutations were confirmed as genetic risk factors for myelodysplastic syndrome, acute myeloid leukemia, and chronic lymphocytic leukemia.

Conclusions:

  • Telomere dysfunction is a key mechanism underlying bone marrow failure in aplastic anemia.
  • Genetic predisposition to telomere shortening contributes to both aplastic anemia and hematologic cancers.
  • Understanding telomere biology is crucial for diagnosing and potentially treating these hematologic disorders.